Abstract
Complaints of weakness without sensory changes in the elderly must evoke the rare, but important, diagnostic categories of motor neuron disease (MND), neuromuscular junction (NMJ) disorders and myopathies. In this chapter we will discuss the last two diagnostic categories, with MND being covered elsewhere. These patients may present with ptosis, diplopia, dysphagia, dysarthria, dyspnea, muscle atrophy and weakness. These complaints are usually not accompanied by other neurologic signs such as spasticity, rigidity, brisk reflexes, ataxia, sensory loss or significant pain. Although other processes such as congenital myasthenic syndromes, botulism poisoning, secondary myopathies from endocrinopathies or steroid use, and even muscular dystrophies can present after the age of 65, the more common neuromuscular junction disorders seen in the elderly include myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS); and the more common myopathies include inflammatory myopathies such as inclusion body myositis (IBM) and necrotizing myopathies. Clues such as fluctuating weakness, slowly progressive weakness, distinct patterns of weakness, and laboratory and electrodiagnostic studies often help in the diagnosis of these disorders. In this chapter, we will review the clinical presentation, diagnostic workup and treatment of MG, LEMS, IBM, the immune-mediated necrotizing myopathies, and briefly touch on dermatomyositis and polymyositis.
References
Amato AA, Russell JA. Neuromuscular disorders. 2nd ed. New York: McGraw Hill; 2015.
Alkhawajah NM, Oger J. Late-onset myasthenia gravis. Muscle Nerve. 2013;48:705–10.
Sanders DB, Guptill JT. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum (Minneap Minn). 2014;20:1413–25.
Jackson CE, Barohn RJ. A pattern recognition approach to myopathy. Continuum (Minneap Minn). 2013;19:1674–97.
O’Rourke KS. Sarcopenia and myopathies in the elderly. In: Nakasato Y, Yung RL, editors. Geriatric rheumatology: a comprehensive approach. New York: Springer; 2011. p. 259–74.
Rose MR, Group EIW. 188th ENMC International Workshop: inclusion body myositis. 2-4 Dec 2011, Naarden, The Netherlands. Neuromuscul Disord. 2013;23:1044–55.
Lahouti AH, Amato AA, Christopher-Stine L. Inclusion body myositis: update. Curr Opin Rheum. 2014;26:690–6.
Amato AA, Sivakumar K, Greenberg SA, et al. Treatment of sporadic inclusion body myositis with bimagrumab. Neurology. 2014;83:2239–46.
Amato AA, Greenberg SA. Inflammatory myopathies. Continuum (Minneap Minn). 2013;19:1615–33.
Wolfe GI, et al. Randomized trial of thymectomy in Myasthenia Gravis. N Engl J Med. 2016;375:511–522
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Chuang, K., Salajegheh, M.K. (2017). Neuromuscular Junction Disorders and Myopathies. In: Tousi, B., Cummings, J. (eds) Neuro-Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-56484-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-56484-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56483-8
Online ISBN: 978-3-319-56484-5
eBook Packages: MedicineMedicine (R0)